Autophagy modulation as a potential _targeted cancer therapy: From drug repurposing to new drug development
- PMID: 33496377
- DOI: 10.1002/kjm2.12361
Autophagy modulation as a potential _targeted cancer therapy: From drug repurposing to new drug development
Abstract
Autophagy is an evolutionarily conserved signaling pathway to deliver dysfunctional proteins or organelles into lysosomes for degradation and recycling, which is an important pathway for normal homeostasis. Autophagy dysfunction can lead to various diseases, particularly cancer. Autophagy not only plays a role in tumor suppression, but it also serves as a tumor promoter in cancer malignancy. In this review, we summarize the involvement of autophagy-related (ATG) proteins in autophagy signaling and the role of autophagy in cancer progression. The effectiveness of US Food and Drug Administration-approved drugs in regulating autophagic flux and suppressing cancer cells is also discussed. Moreover, since clinically available drugs do not specifically _target ATG proteins, there is little doubt that their cancer suppression function is autophagy dependent. Therefore, this review also discusses several inhibitors against ATG proteins, such as ULK1/2, ATG4, and VPS34 to suppress cancer cells. Autophagy modulators can be either used alone or combined with chemotherapy or radiation therapy to enhance the efficacy of current treatments for certain types of cancer. This review summarizes current autophagy modulation used as a potential strategy for _targeted cancer therapy.
Keywords: ATG protein; anti-cancer drug; autophagy; inducer; inhibitor.
© 2021 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University.
Similar articles
-
Therapeutic strategies of drug repositioning _targeting autophagy to induce cancer cell death: from pathophysiology to treatment.J Hematol Oncol. 2017 Mar 9;10(1):67. doi: 10.1186/s13045-017-0436-9. J Hematol Oncol. 2017. PMID: 28279189 Free PMC article. Review.
-
Unraveling the roles of Atg4 proteases from autophagy modulation to _targeted cancer therapy.Cancer Lett. 2016 Apr 1;373(1):19-26. doi: 10.1016/j.canlet.2016.01.022. Epub 2016 Jan 19. Cancer Lett. 2016. PMID: 26805760 Review.
-
Drug Repurposing Screening Identifies Tioconazole as an ATG4 Inhibitor that Suppresses Autophagy and Sensitizes Cancer Cells to Chemotherapy.Theranostics. 2018 Jan 1;8(3):830-845. doi: 10.7150/thno.22012. eCollection 2018. Theranostics. 2018. PMID: 29344310 Free PMC article.
-
4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.Toxicol Appl Pharmacol. 2017 Jun 15;325:48-60. doi: 10.1016/j.taap.2017.04.003. Epub 2017 Apr 10. Toxicol Appl Pharmacol. 2017. PMID: 28408137
-
_targeting autophagic pathways for cancer drug discovery.Chin J Cancer. 2013 Mar;32(3):113-20. doi: 10.5732/cjc.012.10010. Epub 2012 Jul 26. Chin J Cancer. 2013. PMID: 22835386 Free PMC article. Review.
Cited by
-
Drug toxicity assessment: cell proliferation versus cell death.Cell Death Discov. 2022 Oct 14;8(1):417. doi: 10.1038/s41420-022-01207-x. Cell Death Discov. 2022. PMID: 36241623 Free PMC article.
-
Acupoints catgut embedding recovers leptin resistance via improving autophagy progress mediated by AMPK-mTOR signaling in obese mice.Heliyon. 2024 Apr 6;10(7):e29094. doi: 10.1016/j.heliyon.2024.e29094. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38623207 Free PMC article.
-
Clinicopathological Association of Autophagy Related 5 Protein with Prognosis of Colorectal Cancer.Diagnostics (Basel). 2021 Apr 26;11(5):782. doi: 10.3390/diagnostics11050782. Diagnostics (Basel). 2021. PMID: 33926066 Free PMC article.
-
Platinum drugs and taxanes: can we overcome resistance?Cell Death Discov. 2021 Jun 26;7(1):155. doi: 10.1038/s41420-021-00554-5. Cell Death Discov. 2021. PMID: 34226520 Free PMC article. Review.
-
ATG4B and pS383/392-ATG4B serve as potential biomarkers and therapeutic _targets of colorectal cancer.Cancer Cell Int. 2023 Apr 10;23(1):63. doi: 10.1186/s12935-023-02909-7. Cancer Cell Int. 2023. PMID: 37038218 Free PMC article.
References
REFERENCES
-
- Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460-473.
-
- Ghosh R, Pattison JS. Macroautophagy and chaperone-mediated autophagy in heart failure: the known and the unknown. Oxid Med Cell Longev. 2018;1-22.
-
- Liu PF, Farooqi AA, Peng SY, Yu TJ, Dahms HU, Lee CH, et al. Regulatory effects of noncoding RNAs on the interplay of oxidative stress and autophagy in cancer malignancy and therapy. Semin Cancer Biol. 2020;S1044-579X(20):30214-30215.
-
- Zhou C, Ma K, Gao R, Mu C, Chen L, Liu Q, et al. Regulation of mATG9 trafficking by Src- and ULK1-mediated phosphorylation in basal and starvation-induced autophagy. Cell Res. 2017;27(2):184-201.
-
- Otomo C, Metlagel Z, Takaesu G, Otomo T. Structure of the human ATG12~ATG5 conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol. 2013;20(1):59-66.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources